Evangelos Terpos

Citirano

	Sve	Od 2020.
Citati	61167	32232
H-indeks	115	74
i10-indeks	606	446

8000

4000

2000

6000

2004200520062007200820092010201120122013201420152016201720182019202020212022202320242025167 287 505 746 919 1107 1372 1587 1771 1820 2119 2270 2759 2946 3616 3666 4917 6951 7083 6321 5852 952

Javni pristup

Prikaži sve

79 članaka

7 članaka

dostupno

nije dostupno

Na temelju uvjeta financiranja

Suautori

Meletios Athanasios DimopoulosNational and Kapodistrian University of Athens, School of MedicinePotvrđena adresa e-pošte na med.uoa.gr
Kastritis Efstathios OR Castritis Efstath...National and Kapodistrian University of AthensPotvrđena adresa e-pošte na med.uoa.gr
GAVRIATOPOULOU MARIANATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENSPotvrđena adresa e-pošte na med.uoa.gr
Ioannis (John) Ntanasis-StathopoulosNational and Kapodistrian University of Athens, School of MedicinePotvrđena adresa e-pošte na med.uoa.gr
Migkou MagdaliniNational and Kapodistrian University of AthensPotvrđena adresa e-pošte na med.uoa.gr
MARIA ROUSSOUNational and Kapodistrian University of AthensPotvrđena adresa e-pošte na med.uoa.gr
Evangelos Eleutherakis-Papaiakovou...National & Kapodistrian University of AthensPotvrđena adresa e-pošte na med.uoa.gr
Despina FotiouNational and Kapodistrian University of AthensPotvrđena adresa e-pošte na med.uoa.gr
Ioannis TrougakosNational and Kapodistrian University of Athens, Faculty of BiologyPotvrđena adresa e-pošte na biol.uoa.gr
Panagiotis MalandrakisNational and Kapodistrian University of Athens, School of Medicine, Department of Clinical TherapeuticsPotvrđena adresa e-pošte na med.uoa.gr
Argiris SymeonidisUniversity of Patras, GreecePotvrđena adresa e-pošte na upatras.gr
Kyrtsonis M CNational and Kapodistrian University of Athens, Medical SchoolPotvrđena adresa e-pošte na med.uoa.gr
Dimitra GikaNational and Kapodistrian University of AthensPotvrđena adresa e-pošte na med.uoa.gr
marianna politouNational and Kapodistrian University of AthensPotvrđena adresa e-pošte na med.uoa.gr
Athanasios PapatheodorouMolecular BiologistPotvrđena adresa e-pošte na med.uoa.gr
Lia Angela MoulopoulosProfessor of Radiology, School of Medicine, National and Kapodistrian University of AthensPotvrđena adresa e-pošte na med.uoa.gr
Foteini TheodorakakouNational and Kapodistrian University of AthensPotvrđena adresa e-pošte na med.uoa.gr
Ourania TsitsilonisNational and Kapodistrian University of Athens, Department of BiologyPotvrđena adresa e-pošte na biol.uoa.gr
Nora Athina ViniouAssociate Professor in Hematology, National and Kapodistrian University of AthensPotvrđena adresa e-pošte na med.uoa.gr
Michele CavoProfessor of HematologyPotvrđena adresa e-pošte na unibo.it

Prati

Evangelos Terpos

National and Kapodistrian University of Athens

Potvrđena adresa e-pošte na med.uoa.gr

Myeloma Thalassemia Bone Disease Hematology SARS-CoV-2


Naslov Poredaj po navodima Poredaj po godini Poredaj po naslovu	Citirano Citirano	Godina
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ... The lancet oncology 15 (12), e538-e548, 2014	5598	2014
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ... The lancet oncology 17 (8), e328-e346, 2016	2900	2016
Hematological findings and complications of COVID‐19 E Terpos, I Ntanasis‐Stathopoulos, I Elalamy, E Kastritis, TN Sergentanis, ... American journal of hematology 95 (7), 834-847, 2020	2247	2020
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up P Moreau, J San Miguel, P Sonneveld, MV Mateos, E Zamagni, ... Annals of oncology 28, iv52-iv61, 2017	1666*	2017
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors A Bamias, E Kastritis, C Bamia, LA Moulopoulos, I Melakopoulos, ... Journal of clinical Oncology 23 (34), 8580-8587, 2005	1633	2005
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders AV Jones, S Kreil, K Zoi, K Waghorn, C Curtis, L Zhang, J Score, R Seear, ... Blood 106 (6), 2162-2168, 2005	1188	2005
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report A Palumbo, S Bringhen, MV Mateos, A Larocca, T Facon, SK Kumar, ... Blood, The Journal of the American Society of Hematology 125 (13), 2068-2074, 2015	848	2015
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid MA Dimopoulos, E Kastritis, C Bamia, I Melakopoulos, D Gika, M Roussou, ... Annals of Oncology 20 (1), 117-120, 2009	587	2009
Organ-specific manifestations of COVID-19 infection M Gavriatopoulou, E Korompoki, D Fotiou, I Ntanasis-Stathopoulos, ... Clinical and experimental medicine 20, 493-506, 2020	568	2020
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group MA Dimopoulos, E Terpos, A Chanan-Khan, N Leung, H Ludwig, ... Journal of clinical oncology 28 (33), 4976-4984, 2010	536	2010
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group M Cavo, E Terpos, C Nanni, P Moreau, S Lentzsch, S Zweegman, ... The lancet oncology 18 (4), e206-e217, 2017	532	2017
Soluble receptor activator of nuclear factor κB ligand–osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index E Terpos, R Szydlo, JF Apperley, E Hatjiharissi, M Politou, J Meletis, ... Blood 102 (3), 1064-1069, 2003	521	2003
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS) E Voskaridou, D Christoulas, A Bilalis, E Plata, K Varvagiannis, ... Blood, The Journal of the American Society of Hematology 115 (12), 2354-2363, 2010	516	2010
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN) A Palumbo, S Bringhen, H Ludwig, MA Dimopoulos, J Bladé, MV Mateos, ... Blood, The Journal of the American Society of Hematology 118 (17), 4519-4529, 2011	481	2011
International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ... Journal of Clinical Oncology 34 (13), 1544-1557, 2016	472	2016
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders J Hillengass, S Usmani, SV Rajkumar, BGM Durie, MV Mateos, S Lonial, ... The lancet oncology 20 (6), e302-e312, 2019	462	2019
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid MA Dimopoulos, E Kastritis, A Anagnostopoulos, I Melakopoulos, D Gika, ... haematologica 91 (7), 968-971, 2006	462	2006
International Myeloma Working Group recommendations for the treatment of multiple myeloma–related bone disease E Terpos, G Morgan, MA Dimopoulos, MT Drake, S Lentzsch, N Raje, ... Journal of clinical oncology 31 (18), 2347-2357, 2013	457	2013
European Myeloma Network guidelines for the management of multiple myeloma-related complications E Terpos, M Kleber, M Engelhardt, S Zweegman, F Gay, E Kastritis, ... haematologica 100 (10), 1254, 2015	451	2015
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement MA Dimopoulos, J Hillengass, S Usmani, E Zamagni, S Lentzsch, ... Journal of Clinical Oncology 33 (6), 657-664, 2015	443	2015

Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.

Članci 1–20

Godišnji broj citata

Dvostruki navodi

Spojeni navodi

Dodavanje suautoraSuautori

Prati

Citirano

Suautori